I think a small parcel in this one could do very well or...return nothing. highly speculative. Things interest me is the story of MD, the top SH, and number of projects they having. But DYOR!
- Forums
- ASX - By Stock
- RGL
- Ann: Annual General Meeting Presentation
Ann: Annual General Meeting Presentation, page-4
Featured News
Add RGL (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.676M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.7¢ | $28.77K | 4.071M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 10563192 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 2430283 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2063981 | 0.007 |
22 | 10729858 | 0.006 |
38 | 15848684 | 0.005 |
13 | 8099245 | 0.004 |
11 | 13946667 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 7745305 | 16 |
0.009 | 7720969 | 17 |
0.010 | 4103118 | 10 |
0.011 | 3192850 | 7 |
0.012 | 60000 | 1 |
Last trade - 11.00am 16/07/2024 (20 minute delay) ? |
Featured News
RGL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online